Open Access

Inhibition of p38MAPK and CD137 signaling reduce dengue virus-induced TNF-α secretion and apoptosis

  • Amar Nagila1, 2,
  • Janjuree Netsawang5,
  • Aroonroong Suttitheptumrong1, 4,
  • Atthapan Morchang1, 4,
  • Sasiprapa Khunchai1, 4,
  • Chatchawan Srisawat,
  • Chunya Puttikhunt6,
  • Sansanee Noisakran6,
  • Pa-thai Yenchitsomanus1 and
  • Thawornchai Limjindaporn1, 3Email author
Contributed equally
Virology Journal201310:105

DOI: 10.1186/1743-422X-10-105

Received: 14 December 2012

Accepted: 2 April 2013

Published: 4 April 2013

Abstract

Background

Hepatic injury in dengue virus (DENV) infection is authenticated by hepatomegaly and an upsurge in transaminase levels. DENV replicates in hepatocytes and causes hepatocyte apoptosis both in vitro and in vivo. Understanding the molecular mechanisms of DENV-induced hepatic injury could facilitate the development of alternate chemotherapeutic agents and improved therapies.

Findings

The p38 mitogen-activated protein kinase (MAPK) participates in both apoptosis-related signaling and pro- inflammatory cytokine production. The role of p38 MAPK in DENV-infected HepG2 cells was examined using RNA interference. The results showed that DENV infection activated p38 MAPK and induced apoptosis. The p38 MAPK activation and TNF-α production were controlled by p38 MAPK and CD137 signaling in DENV-infected HepG2 cells as activated p38 MAPK, TNF-α and apoptosis were significantly decreased in p38 MAPK and CD137 depleted DENV-infected HepG2 cells. Addition of exogenous TNF-α to p38 MAPK depleted DENV-infected HepG2 cells restored DENV-induced apoptosis in HepG2 cells.

Conclusion

DENV induces CD137 signaling to enhance apoptosis by increasing TNF-α production via activation of p38 MAPK.

Keywords

Dengue virus Apoptosis TNF-α p38MAPK CD137

Findings

Hepatic dysfunction is a crucial feature of DENV infection. Hepatic biopsy specimens obtained from fatal cases of dengue shock syndrome (DSS) show cellular apoptosis, which may relate to the pathogenesis of DSS [1, 2]. DENV replicates in hepatocytes and apoptosis of DENV-infected hepatic cells has been observed both in vitro and in vivo. Both the cell death receptor and the mitochondrial apoptotic pathways are affected [39].

DENV capsid protein (DENV C) activates both extrinsic and intrinsic apoptotic pathways in hepatic cell lines [1012]. DENV C localizes to both the cytoplasm and nucleus of DENV-infected HepG2 cells. DENV C contains three nuclear localization signals (NLS), 6KKAR9, 73KKSK76 and the bipartite signal 85RKeigrmlnilnRRRR100. Substitution mutations in DENV C (R85A/K86A) result in loss of nuclear localization, Daxx interaction, and apoptosis [11]. Comparison of the apoptotic gene expression profile of DENV C and DENV C (R85A/K86A) transfected HepG2 cells showed a significant increase in expression of CD137, a member of TNF receptor family, in HepG2 cells expressing DENV C. In DENV-infected HepG2 cells, CD137 and CD137 ligand mRNA expression increased 60-fold and 3-fold post DENV infection, respectively. CD137 positive cells increased, but less dramatically, about 3-fold post infection and correlates with the level of apoptosis induced by DENV infection of HepG2 cells, which increased 4-fold post DENV infection [13].

CD137 recruits TNF receptor associated factor 2 (TRAF2) and activates apoptosis signal regulating kinase 1 (ASK1), resulting in activation of cJun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) [14]. p38 MAPK is primarily implicated in apoptosis-related signaling [15]. However, activation of p38 MAPK increases inflammatory cytokine production [16]. Activation of p38 MAPK may contribute to the pathogenesis of DENV-induced apoptosis via both mechanisms.

Inhibition of DENV-induced apoptosis in HepG2 cells by siRNA against p38 MAPK

We first asked whether RNAi knockdown of p38α MAPK, which is a crucial mediator of proinflammatory cytokine production, would inhibit DENV-induced apoptosis in HepG2 cells, an approach that might alleviate DENV-mediated hepatic injury. At 24 h after seeding, HepG2 cells were transfected with 200 pmol of siRNA directed against p38α MAPK, 5CAGACCATATTAACCAGCTTCAGCA3 or with siControl, 5 CACGCCTCTTTGTCTTGTTTCGAAA 3 (Invitrogen), using lipofectamine 2000 (Invitrogen). Twenty-four hours post transfection, the cells were infected with DENV serotype 2 strain 16681 at an MOI of 5 using the methods described previously [13]. The percentage of apoptotic cells was determined by annexin V/FITC and PI double staining (BD Biosciences) and quantitation by flow cytometry. The efficiency of p38α MAPK knockdown by siRNA was examined by real-time RT-PCR using p38α MAPK-specific primers (p38α MAPK-F, 5CGACTTGCTGGAGAAGATGC3, and p38α MAPK-R, 5TCCATCTCTTCTTGGTCAAGG3) and by Western blot analysis using primary antibodies against p38 MAPK and β-actin (Santa Cruz Biotechnology). About 30% decreases in both mRNA and protein expression levels of p38 MAPK were observed (Figure 1A, 1B). In addition, treatment with siRNA against p38 MAPK reduced apoptosis from 23.43% to 16.53% in DENV-infected HepG2 cells (Figure 1C, D) suggesting a role for p38 MAPK in DENV-mediated apoptosis. The result of siRNA directed against p38 MAPK in DENV-infected HepG2 cells is agreeable to our previous study of pharmacological inhibition of p38 MAPK by SB203580 in DENV-infected HepG2 cells [17]. Therefore, genetic inhibition of p38 activity reproduces pharmacological inhibition of the enzyme and confirms the contribution of p38 MAPK to apoptotic events induced by DENV [17]. DENV infected HepG2 cells equally in the presence or absence of SB203580 [17] but DENV production in BHK-21 cells was decreased in the presence of SB203580 [18].
https://static-content.springer.com/image/art%3A10.1186%2F1743-422X-10-105/MediaObjects/12985_2012_Article_2108_Fig1_HTML.jpg
Figure 1

Decreased apoptosis in p38 MAPK knockdown DENV-infected HepG2 cells. HepG2 cells were transfected either with siRNA directed against p38 MAPK or with control siRNA. Twenty-four hours post transfection, cells were infected with DENV at MOI 5 for 60 h. Cells were harvested and analyzed for (A) mRNA level of p38 MAPK (B) protein level of p38 MAPK. (C) Apoptosis by flow cytometry. Apoptosis cells have annexin V+/PI- staining. (D) Bar graph represents apoptosis experiments. All data were obtained from three independent experiments and reported as the mean ± SEM. Statistical differences between the groups were tested with an unpaired t-test using StatView version 5.0 and P value less than 0.05 was considered significant.

Inhibition of DENV C-induced apoptosis in stable HepG2 cell expressing DENV C by siRNA against p38 MAPK

We next asked whether DENV C activates p38 MAPK-induced apoptosis by examining the effect of siRNA against p38α MAPK on apoptosis of HepG2 cells stably expressing DENV C. HepG2 cells stably expressing DENV C were constructed in this study using retroviral system (Stratagene). Briefly, 70% confluent of HEK 293T cells was transfected with p-VPack-GP, p-VPack-VSV-G and pFB-Neo-DENV C using lipofectamine 2000 (Invitrogen). The culture supernatant containing infectious viral particles was collected after 24 h post transfection and added to HepG2 cells, which were pre-incubated with 8 μg / ml of polybrene. Twenty-four h after incubation, stable HepG2 cells expressing DENV C were selected with media containing 0.5 mg/ml G418 (Calbiochem). The G418-resistant cells were grown and maintained in DMEM medium containing 0.5 mg/ml G418, and the expression of DENV C was examined by flow cytometry and Western blot analysis using antibody to DENV C [19]. Up to 5 × 105 the stably expressing cells were plated for 24 h prior to transfection. The cells were then transfected with siRNAs as described in the preceding experiment. Knock-down efficiency was assessed by Western blot analysis. The 15 kDa capsid protein was expressed in stable HepG2 cells expressing DENV but not in HepG2 cells expressing control plasmid (Figure 2A). To activate the extrinsic apoptotic pathway, cells were treated with 0.5 μg/ml anti-Fas mAb (Sigma) and 1 ug/ml cycloheximide (Sigma) for 24 h in culture medium. Both adherent and floating cells, as well as culture supernatants, were collected and assessed for apoptosis by annexinV/PI staining (BD Biosciences). As with DENV-infected cells, siRNA p38α MAPK resulted in a substantial reduction in p38 MAPK protein, but had no effect on DENV C expression (Figure 2A). In the presence of anti-Fas and cycloheximide, apoptosis of HepG2 cells expressing DENV C increased from 7.79% to 32.83% compared to that of HepG2 cells expressing control plasmid. HepG2 cells expressing DENV C transfected with p38 MAPK siRNA reduced apoptosis from 32.83% to 23% (Figure 2B, 2C). In our previous study without anti-Fas mAb and cycloheximide treatment, HepG2 cells were transiently transfected with a DENV C or control plasmid and incubated in the presence of DMSO or 10 μM of SB203580 for 24 h. The percentage of apoptotic cells was then determined by annexin V/FITC and PI double staining and quantitation by flow cytometry. Comparable to apoptosis of HepG2 cells expressing control plasmid, apoptosis of HepG2 cells expressing DENV C increased from 10.11% to 24.40%. Apoptosis of HepG2 cells expressing DENV C decreased from 24.40% to 5.69% in medium with SB203580 [17]. Therefore, genetic inhibition of p38 activity reproduces pharmacological inhibition of the enzyme and verifies the contribution of p38 MAPK to apoptotic events induced specifically by DENV C. However, not all DENV-induced cell death is caused by DENV C, other DENV proteins including M, NS3 protease and NS2B-NS3 precursor also induces apoptosis [20, 21].
https://static-content.springer.com/image/art%3A10.1186%2F1743-422X-10-105/MediaObjects/12985_2012_Article_2108_Fig2_HTML.jpg
Figure 2

Decreased apoptosis in p38 MAPK knockdown HepG2 cells expressing DENV C. HepG2 cells expressing DENV C or control plasmid were transfected either with siRNA directed against p38 MAPK or with control siRNA and then treated with 0.5 μg/ml anti-Fas mAb and 1 ug/ml cycloheximide for 24 h. Cells were collected and analyzed for (A) p38 MAPK, DENV C and actin (B) Bar graph represents apoptosis experiments. All data were obtained from three independent experiments and reported as the mean ± SEM. Statistical differences between the groups were tested with an unpaired t-test using StatView version 5.0 and P value less than 0.05 was considered significant. (C) Apoptosis by flow cytometry.

Inhibition of DENV-induced phosphorylated p38 MAPK, TNF-α production and apoptosis in HepG2 cells by siRNA against CD137

To further define the molecular mechanisms involved, we asked whether CD137 signaling regulates p38 MAPK activation and apoptosis in DENV-infected HepG2 cells. siRNA knockdown of CD137 was performed as described for p38 MAPK using the CD137-specific oligo 5CACGCTCCGTTTCTCTGTTGTTAAA 3 (Invitrogen). The efficiency of knockdown was examined by real-time RT-PCR using CD137-specific primers CD137-F, 5CCA AAA TGT TCT GCT GAT CG3 and CD137-R, 5 AAG ACT GTG GCG CCC TG3. The number of CD 137 positive cells was measured by flow cytometry using a primary antibody against CD137 (Santa Cruz Biotechnology). Transfection of HepG2 cells with siRNA against CD137 resulted in a nearly 2-fold reduction in CD137 mRNA and CD137-positive cells (Figure 3A, 3B). The effect of CD137 depletion on p38 MAPK activation during DENV infection and apoptosis were measured by Western blot analysis using primary antibody against phosphorylated p38 MAPK (Santa Cruz Biotechnology), and by annexinV/PI staining (BD Biosciences), respectively. Knockdown of CD137 expression reduced the amount of phosphorylated p38 MAPK (Figure 3C) and apoptosis (Figure 3D). These results indicate a role of CD137 signaling in regulation of p38 MAPK activation and apoptosis in DENV-infected HepG2 cells. As DENV induced CD137 expression only 30% of the infected cells (Figure 3B) and expressed at the late stage of infection [13], CD137 and p38 MAPK signaling may support other apoptotic signaling pathways [39] to aggravate apoptosis at the late stage of DENV infection. Multiple studies in vitro and in vivo models implicate TNF-α in DENV-induced tissue damage [8, 22]. In addition, TNF-α induced apoptosis via p38 MAPK activation was shown in pseudorabies virus infection [23].
https://static-content.springer.com/image/art%3A10.1186%2F1743-422X-10-105/MediaObjects/12985_2012_Article_2108_Fig3_HTML.jpg
Figure 3

Reduced DENV-induced phosphorylated p38 MAPK, TNF-α and apoptosis in HepG2 cells by siRNA against CD137. HepG2 cells were transfected with either CD137 siRNA or control siRNA. Twenty-four hours post transfection, cells were infected with DENV at MOI 5 for 60 h. Cells were collected and analyzed for (A) CD137 mRNA (B) CD137 positive cells (C) phosphorylation of p38 and (D) Apoptosis by flow cytometry. The cells were collected and analyzed for TNF-α mRNA (E) and the culture supernatant was analyzed for TNF-α protein (F). All data were obtained from three independent experiments and reported as the mean ± SEM. Statistical differences between the groups were tested with an unpaired t-test using StatView version 5.0 and P value less than 0.05 was considered significant.

We next asked whether TNF-α mediated DENV-induced apoptosis via CD137 signaling. TNF-α expression in CD137 depleted DENV-infected HepG2 cells was examined by real-time RT-PCR using TNF-α-specific primers TNF-α-F, 5TGCTTGTTCCTCAGCCTCTT3,and TNF-α-R, 5 ATGGGCTACAGGCTTGTCACT3 and by ELISA (R&D Systems). DENV infection of HepG2 cells resulted in a dramatic increase in TNF-α mRNA and protein (Figure 3E, 3F). However, CD137 siRNA treatment reduced of TNF-α production about 30% (Figure 3E, 3F), which correlates well with the comparable reduction in apoptosis of CD137 knockdown cells (Figure 3D).

Inhibition of p38 MAPK activity by SB203580 decreased TNF-α production in DENV-infected HepG2 cells

As p38 MAPK is one of the downstream targets of CD137 signaling, it is important to assess whether inhibition of p38 MAPK activity in DENV-infected HepG2 cells would reduce TNF-α expression. HepG2 cells were infected with DENV serotype 2 at a MOI 5 and incubated 48 h in the presence of either DMSO or 10 μM SB203580 (Santa Cruz Biotechnology). TNF-α mRNA expression of DENV-infected HepG2 cells and TNF-α protein expression in supernatant of DENV-infected HepG2 cells were subsequently examined by real-time RT-PCR and by ELISA, respectively. As expected, treatment with 10 μM SB203580 significantly reduced TNF-α expression in DENV-infected HepG2 cells (Figure 4A, 4B) indicating that pharmacological inhibition of p38 MAPK reduced TNF-α secretion in DENV-infected HepG2 cells. Whether inhibition of both p38 and CD137 signalings has the additive effect on TNF-α production merits further investigation.
https://static-content.springer.com/image/art%3A10.1186%2F1743-422X-10-105/MediaObjects/12985_2012_Article_2108_Fig4_HTML.jpg
Figure 4

Reduced DENV-induced TNF-α production and apoptosis in SB203580 treated DENV-infected HepG2 cells and exogenous TNF-α restored the apoptosis. (A) HepG2 cells were infected with DENV serotype 2 at a MOI 5 and incubated 48 h in the presence of either DMSO or 10 μM SB203580. TNF-α mRNA (A) and TNF-α protein (B) expression of DENV-infected HepG2 cells was subsequently examined by real-time RT-PCR and by ELISA, respectively. All data were obtained from three independent experiments and reported as the mean ± SEM. Statistical differences between the groups were tested with an unpaired t-test using StatView version 5.0 and P value less than 0.05 was considered significant. (C) Supernatants containing DENV from mock-infected or DENV-infected HepG2 cells in the presence of either DMSO or 10 μM SB203580 was isolated and incubated with HepG2 cells in the presence or absence of recombinant TNF-α. The percentage of apoptotic cells was then determined at 72 h by annexin V/FITC and PI double staining and quantitation by flow cytometry. Apoptosis cells have annexin V+/PI- staining. (D) Model representing the augmentation of DENV-induced apoptosis mediated by TNF-α via the activation of p38 MAPK and CD137 signaling.

The role of TNF-α expression in apoptosis of DENV-infected HepG2 cells

It would be important to evaluate the effect of TNF-α expression in apoptosis of DENV-infected HepG2 cells. Supernatants containing DENV from mock-infected or DENV-infected HepG2 cells in the presence of either DMSO or 10 μM SB203580 was isolated and further incubated with HepG2 cells in the presence or absence of recombinant TNF-α (250 ng/ml)(Sigma). The percentage of apoptotic cells was then determined at 72 h by annexin V/FITC and PI double staining and quantitation by flow cytometry. The result in Figure 4C showed that apoptosis of DENV-infected HepG2 cells decreased from 22% to 11.59% when HepG2 cells were incubated with supernatant containing virus from SB203580 treated DENV-infected HepG2 cells. Addition of recombinant TNF-α to supernatant from SB203580 treated DENV-infected HepG2 cells increased apoptosis of DENV-infected HepG2 cells from 11.59% to 17.89% (Figure 4C) suggesting that TNF-α production affects DENV-induced apoptosis of HepG2 cells. Our result supports the previous studies for the role of TNF-α expression in DENV-induced apoptosis in other cell lines. TNF-α produced from macrophage was shown to enhance DENV-induced endothelial cell death [24] and inhibition of peripheral blood mononuclear cell (PBMC) apoptosis by etanercept, which is the antibody to TNF-α, was also reported [25]. In summary, we propose in Figure 4D that DENV induces phosphorylated p38 MAPK to stimulate apoptosis and inhibition of p38 MAPK and CD137 pathway reduce DENV-induced TNF-α secretion and apoptosis of HepG2 cells.

Declarations

Acknowledgements

We appreciate Dr. William A Fonzi, Georgetown University, USA, for the critical reading and editing of this manuscript. This work was financially supported by Mahidol University Grant and Siriraj Research Developmental Fund to T.L., who is a Mid-Career Thailand Research Fund–Commission of Higher Education (TRF-CHE) Research Scholar. PY is a TRF-Senior Research Scholar. JN is a TRF-CHE Young Research Scholar. AM was supported by TRF-Royal Golden Jubilee (TRF-RGJ) Ph.D. Program. SK was supported by CHE under the program strategic scholarship for frontier research network for the join Ph.D. program. AS was supported by Siriraj Developmental Scholarship and AN was supported by Siriraj Graduate Thesis Scholarship. All authors obtained permission to acknowledge the source of funding.

Authors’ Affiliations

(1)
Division of Molecular Medicine, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University
(2)
Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University
(3)
Department of Anatomy, Faculty of Medicine Siriraj Hospital, Mahidol University
(4)
Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University
(5)
Faculty of Medical Technology, Rangsit University
(6)
Medical Biotechnology Research Unit, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency

References

  1. Bhamarapravati N: Hemostatic defects in dengue hemorrhagic fever. Rev Infect Dis 1989,11(Suppl 4):S826-S829.PubMedView Article
  2. Limonta D, Capo V, Torres G, Perez AB, Guzman MG: Apoptosis in tissues from fatal dengue shock syndrome. J Clin Virol 2007, 40: 50-54. 10.1016/j.jcv.2007.04.024PubMedView Article
  3. Marianneau P, Cardona A, Edelman L, Deubel V, Despres P: Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death. J Virol 1997, 71: 3244-3249.PubMedPubMed Central
  4. Thongtan T, Panyim S, Smith DR: Apoptosis in dengue virus infected liver cell lines HepG2 and Hep3B. J Med Virol 2004, 72: 436-444. 10.1002/jmv.20004PubMedView Article
  5. Nasirudeen AM, Liu DX: Gene expression profiling by microarray analysis reveals an important role for caspase-1 in dengue virus-induced p53-mediated apoptosis. J Med Virol 2009, 81: 1069-1081. 10.1002/jmv.21486PubMedView Article
  6. El-Bacha T, Midlej V, da Silva Pereira AP, da Costa Silva L, Benchimol M, Galina A, Da Poian AT: Mitochondrial and bioenergetic dysfunction in human hepatic cells infected with dengue 2 virus. Biochim Biophys Acta 2007, 1772: 1158-1166. 10.1016/j.bbadis.2007.08.003PubMedView Article
  7. Matsuda T, Almasan A, Tomita M, Tamaki K, Saito M, Tadano M, Yagita H, Ohta T, Mori N: Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand. J Gen Virol 2005, 86: 1055-1065. 10.1099/vir.0.80531-0PubMedPubMed CentralView Article
  8. Wati S, Rawlinson SM, Ivanov RA, Dorstyn L, Beard MR, Jans DA, Pitson SM, Burrell CJ, Li P, Carr JM: Tumour necrosis factor alpha (TNF-{alpha}) stimulation of cells with established dengue virus type 2 infection induces cell death that is accompanied by a reduced ability of TNF-{alpha} to activate nuclear factor {kappa}B and reduced sphingosine kinase-1 activity. J Gen Virol 2011, 92: 807-818. 10.1099/vir.0.028159-0PubMedView Article
  9. Liao H, Xu J, Huang J: FasL/Fas pathway is involved in dengue virus induced apoptosis of the vascular endothelial cells. J Med Virol 2010, 82: 1392-1399. 10.1002/jmv.21815PubMedView Article
  10. Limjindaporn T, Netsawang J, Noisakran S, Thiemmeca S, Wongwiwat W, Sudsaward S, Avirutnan P, Puttikhunt C, Kasinrerk W, Sriburi R: Sensitization to Fas-mediated apoptosis by dengue virus capsid protein. Biochem Biophys Res Commun 2007, 362: 334-339. 10.1016/j.bbrc.2007.07.194PubMedView Article
  11. Netsawang J, Noisakran S, Puttikhunt C, Kasinrerk W, Wongwiwat W, Malasit P, Yenchitsomanus PT, Limjindaporn T: Nuclear localization of dengue virus capsid protein is required for DAXX interaction and apoptosis. Virus Res 2010, 147: 275-283. 10.1016/j.virusres.2009.11.012PubMedView Article
  12. Nasirudeen AM, Wang L, Liu DX: Induction of p53-dependent and mitochondria-mediated cell death pathway by dengue virus infection of human and animal cells. Microbes Infect 2008, 10: 1124-1132. 10.1016/j.micinf.2008.06.005PubMedView Article
  13. Nagila A, Netsawang J, Srisawat C, Noisakran S, Morchang A, Yasamut U, Puttikhunt C, Kasinrerk W, Malasit P, Yenchitsomanus PT, Limjindaporn T: Role of CD137 signaling in dengue virus-mediated apoptosis. Biochem Biophys Res Commun 2011, 410: 428-433. 10.1016/j.bbrc.2011.05.151PubMedView Article
  14. Sollner L, Shaqireen DOKMM, Wu JT, Schwarz H: Signal transduction mechanisms of CD137 ligand in human monocytes. Cell Signal 2007, 19: 1899-1908. 10.1016/j.cellsig.2007.04.014PubMedView Article
  15. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270: 1326-1331. 10.1126/science.270.5240.1326PubMedView Article
  16. Ono K, Han J: The p38 signal transduction pathway: activation and function. Cell Signal 2000, 12: 1-13. 10.1016/S0898-6568(99)00071-6PubMedView Article
  17. Morchang A, Yasamut U, Netsawang J, Noisakran S, Wongwiwat W, Songprakhon P, Srisawat C, Puttikhunt C, Kasinrerk W, Malasit P: Cell death gene expression profile: role of RIPK2 in dengue virus-mediated apoptosis. Virus Res 2011, 156: 25-34. 10.1016/j.virusres.2010.12.012PubMedView Article
  18. Ceballos-Olvera I, Chavez-Salinas S, Medina F, Ludert JE, del Angel RM: JNK phosphorylation, induced during dengue virus infection, is important for viral infection and requires the presence of cholesterol. Virology 2009, 396: 30-36.PubMedView Article
  19. Puttikhunt C, Ong-Ajchaowlerd P, Prommool T, Sangiambut S, Netsawang J, Limjindaporn T, Malasit P, Kasinrerk W: Production and characterization of anti-dengue capsid antibodies suggesting the N terminus region covering the first 20 amino acids of dengue virus capsid protein is predominantly immunogenic in mice. Arch Virol 2009, 154: 1211-1221. 10.1007/s00705-009-0426-5PubMedView Article
  20. Catteau A, Kalinina O, Wagner MC, Deubel V, Courageot MP, Despres P: Dengue virus M protein contains a proapoptotic sequence referred to as ApoptoM. J Gen Virol 2003, 84: 2781-2793. 10.1099/vir.0.19163-0PubMedView Article
  21. Shafee N, AbuBakar S: Dengue virus type 2 NS3 protease and NS2B-NS3 protease precursor induce apoptosis. J Gen Virol 2003, 84: 2191-2195. 10.1099/vir.0.19022-0PubMedView Article
  22. Yen YT, Chen HC, Lin YD, Shieh CC, Wu-Hsieh BA: Enhancement by tumor necrosis factor alpha of dengue virus-induced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development. J Virol 2008, 82: 12312-12324. 10.1128/JVI.00968-08PubMedPubMed CentralView Article
  23. Yeh CJ, Lin PY, Liao MH, Liu HJ, Lee JW, Chiu SJ, Hsu HY, Shih WL: TNF-alpha mediates pseudorabies virus-induced apoptosis via the activation of p38 MAPK and JNK/SAPK signaling. Virology 2008, 381: 55-66. 10.1016/j.virol.2008.08.023PubMedView Article
  24. Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA: Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol 2007, 81: 5518-5526. 10.1128/JVI.02575-06PubMedPubMed CentralView Article
  25. Jaiyen Y, Masrinoul P, Kalayanarooj S, Pulmanausahakul R, Ubol S: Characteristics of dengue virus-infected peripheral blood mononuclear cell death that correlates with the severity of illness. Microbiol Immunol 2009, 53: 442-450. 10.1111/j.1348-0421.2009.00148.xPubMedView Article

Copyright

© Nagila et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement